Bioscrip has announced a life sciences IPO for common stock worth $75million.

Auris Medical secures $50.6 Million in Series C financing deal.

Anthera Pharmaceuticals announced the pricing of an underwritten pharma IPO of 60,606,061 shares of its common stock, offered at a price of $0.66 per share

Horizon Pharma announced the execution of a securities purchase agreement with a select group of institutional and accredited investors providing for a private placement financing.